Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

emirates247.com - WAM - ADCAN Pharma, Menarini partner to strengthen UAE's pharmaceutical manufacturing industry
ADCAN Pharma, Menarini partner to strengthen UAE's pharmaceutical manufacturing industry
Emirates 24|7

Abu Dhabi: ADCAN Pharma, a leading UAE-based pharmaceutical manufacturer distinguished as the nation's first producer of oncology and hormone products, has announced a formal partnership with Menarini, an international pharmaceutical company…

globenewswire.com - Zealand Pharma - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire

Company announcement – No. 24 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, June 10, 2026 –…

thehindubusinessline.com - Stock to buy today: Ajanta Pharma (₹3,073) - BUY
Stock to buy today: Ajanta Pharma (₹3,073) - BUY
BusinessLine

The short-term outlook is bullish for Ajanta Pharma. The stock is moving in a bull channel since November last year. The recent bounce has happened from just above the lower end of the channel. The chances are high for the stock go up towards the…

energyandcapital.com - Ending Big Pharma's $2.6 Billion Coin Flip
Ending Big Pharma's $2.6 Billion Coin Flip
Energy & Capital -

When a Hungarian physician named Ignaz Semmelweis noticed something peculiar in the maternity ward he was running at Vienna General Hospital, it kept him awake for weeks. Women were dying… but not from childbirth. They were dying because of…

thehindubusinessline.com - KS Badri Narayanan - Stock Market Today Live: Stock to buy today: Ajanta Pharma (₹3,073) - BUY
Stock Market Today Live: Stock to buy today: Ajanta Pharma (₹3,073) - BUY
BusinessLine

Sensex Today, Nifty 50 | Stock Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 11th June 2026 The short-term outlook is bullish for Ajanta Pharma. The stock is…

marketbeat.com - Heartland Advisors Inc. Grows Position in Royalty Pharma PLC $RPRX
Heartland Advisors Inc. Grows Position in Royalty Pharma PLC $RPRX
MarketBeat

Heartland Advisors Inc. boosted its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 121.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 213,989 shares of…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0710 GMT – AstraZeneca's data on its experimental obesity pill look surprisingly competitive, even if…

globenewswire.com - Orion Oyj - Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
GlobeNewswire

STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the…

technologyreview.com - Anna Gibbs - Job titles of the future: Nature's drug designer
Job titles of the future: Nature's drug designer
MIT Technology Review

In 2018, after nearly two decades working in Big Pharma, chemist Tim Cernak was ready to put his skills to a new use. For Merck, he'd developed precision therapies for cancer, HIV, and diabetes that could target disease while minimizing harm to…

forbes.com - Naazneen Karmali - Track Young Frontrunners In The 11th Edition Of The 30 Under 30 Asia List In Forbes
Track Young Frontrunners In The 11th Edition Of The 30 Under 30 Asia List In Forbes
Forbes

O pportunities often come unannounced. To the astute person who quickly acts upon them and plunges, as Goethe describes it, “boldly into the thick of life,” accrue the spoils. This edition is filled with examples of such risk-takers.

thestandard.com.hk - Judy Cui - HKSTP to lead Hong Kong start-ups to go global via VivaTech Paris and BIO San Diego
HKSTP to lead Hong Kong start-ups to go global via VivaTech Paris and BIO San Diego
The Standard

Hong Kong Science and Technology Parks Corporation (HKSTP) is set to lead two major overseas delegations of local start-ups specializing in AI, green technology, and life and health tech to France and the United States this June to explore global…

rediff.com - Nandita Malik - Indian Stock Market Falls: US-Iran Tensions, FII Outflows, US Inflation Impact Sensex, Nifty
Indian Stock Market Falls: US-Iran Tensions, FII Outflows, US Inflation Impact Sensex, Nifty
Rediff.com

Indian equity markets, including the Sensex and Nifty, experienced a downturn on Thursday, influenced by escalating US-Iran tensions, significant foreign fund outflows, and rising US inflation concerns. Indian benchmark indices, Sensex and Nifty…

scmp.com - Jolene Otremba - From Sick Care to Healthcare
From Sick Care to Healthcare
South China Morning Post

He breaks it down simply. “S stands for sales, I stands for innovation and T… many people will think T stands for technology… but actually it's talent.” Sales remains essential, he says, calling it “the…

thehill.com - Joseph Choi - Voters lean in favor of codifying Trump's MFN policy
Voters lean in favor of codifying Trump's MFN policy
The Hill

Conducted by Democratic polling firm Lake Research Partners, the poll found drug pricing is high on the list of voters' priorities ahead of November's midterm elections. Nearly 6 in 10 voters said they believe prescription drug prices have not gone…

fortune.com - Lily Mae Lazarus - Abridge wants to be the operating system for medicine-and NVIDIA and Eli Lilly are helping build it
Abridge wants to be the operating system for medicine-and NVIDIA and Eli Lilly are helping build it
Fortune

On Thursday morning in New York City, Dr. Shiv Rao stood before a room of health system executives and made a case that ambient AI—a technology that began largely as a transcription tool—was ready to do something far more…

Receive a Daily briefing on Pharma Industry News

Get Started